We reported a marked increase in the pl-GFAP levels of sCJD patients compared to the np-RPD patients and HCs, likely reflecting the significant astrocyte activation occurring in prion disease as a response to PrPSc misfolding and aggregation [16,17]. The gene discussed is GFAP; the disease is prion disease.